PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers

Current studies aiming at identifying single immune markers with prognostic value have limitations in the context of complex antitumor immunity and cancer immune evasion. Here, we show how the integration of several immune markers influences the predictions of prognosis of gastric cancer (GC) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Le, Yan, Feng, Meng, Qiaohong, Yu, Liang, Yuan, Xiangliang, Gantier, Michael P., Williams, Bryan R. G., Chan, David W., Shi, Liyun, Tu, Yugang, Ni, Peihua, Wang, Xuefeng, Chen, Weisan, Zang, Xingxing, Xu, Dakang, Hu, Yiqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980489/
https://www.ncbi.nlm.nih.gov/pubmed/29872566
http://dx.doi.org/10.1080/2162402X.2018.1433520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980489/
https://www.ncbi.nlm.nih.gov/pubmed/29872566
http://dx.doi.org/10.1080/2162402X.2018.1433520

Ejemplares similares